INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 43m ago
House PTR3m ago
SEC 13F2m ago
Robinhood Chain2m ago

Results

74,179 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
21
MI
Mecklenburg Gabriel M.I.Director, Exec. Chairman & Co-Founder
HNGEHinge Health, Inc.
Open-market sale · 10b5-1 plan
SELL$1.52M
16.5K sh
Sep 14, 2026
Page 423 of 1855
← PrevNext →
Sep 15, 2026
traded Sep 14, 2026
+1d
SEC Form 4

Evidence

21
MF
Montoya Michael FChief Technology Ops Officer
FFIVF5, INC.
Open-market sale · 10b5-1 plan
SELL$182K
440 sh
Sep 14, 2026Sep 15, 2026
traded Sep 14, 2026
+1dSEC Form 4

Evidence

21
PF
Perkins David F.Vice President
NONENONESterling Real Estate Trust
Open-market sale
SELL$25.5
1 sh
Sep 14, 2026Sep 15, 2026
traded Sep 14, 2026
+1dSEC Form 4

Evidence

21
MG
Mulhern GeorgeDirector
INSGINSEEGO CORP.
Grant or award
A—
19.7K sh
Sep 11, 2026Sep 15, 2026
traded Sep 11, 2026
+4dSEC Form 4

Evidence

21
KC
Keswani Sanjay ChandruChief Medical Officer
NBIXNEUROCRINE BIOSCIENCES INC
Grant or award
A—
3,914 sh
Sep 11, 2026Sep 15, 2026
traded Sep 11, 2026
+4dSEC Form 4

Evidence

21
CC
Chen Sean ChihhsiangPresident and COO
AMBQAmbiq Micro, Inc.
Open-market sale · 10b5-1 plan
SELL$663K
11.0K sh
Sep 14, 2026Sep 15, 2026
traded Sep 14, 2026
+1dSEC Form 4

Evidence

21
VS
Venkatramani SrinivasanHead of Product Tech & Cust Op
BLNDBlend Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$107K
74.7K sh
Sep 11, 2026Sep 15, 2026
traded Sep 11, 2026
+4dSEC Form 4

Evidence

21
EF
Esaka FumihideDirector, Chief Executive Officer
AMBQAmbiq Micro, Inc.
Open-market sale · 10b5-1 plan
SELL$2.66M
42.1K sh
Sep 11, 2026Sep 15, 2026
traded Sep 11, 2026
+4dSEC Form 4

Evidence

21
JC
Joseph Paul CEVP - Global Sales
AKAMAKAMAI TECHNOLOGIES INC
Open-market sale · 10b5-1 plan
SELL$327K
3,100 sh
Sep 15, 2026Sep 15, 2026
traded Sep 15, 2026
+0dSEC Form 4

Evidence

21
WW
Weibel Paul Wesley IIIChief Executive Officer
FEAM5E Advanced Materials, Inc.
Option exercise
M—
3,409 sh
Sep 15, 2026Sep 15, 2026
traded Sep 15, 2026
+0dSEC Form 4

Evidence

21
MI
Mecklenburg Gabriel M.I.Director, Exec. Chairman & Co-Founder
HNGEHinge Health, Inc.
Open-market sale · 10b5-1 plan
SELL$1.07M
11.7K sh
Sep 14, 2026Sep 15, 2026
traded Sep 14, 2026
+1dSEC Form 4

Evidence

20
MN
Mesa NildaDirector
UTHRUNITED THERAPEUTICS Corp
Open-market sale
SELL$66K
130 sh
Sep 14, 2026Sep 15, 2026
traded Sep 14, 2026
+1dSEC Form 4

Evidence

20
SB
Sousa Mauad BrunoDirector
AUGOAura Minerals Inc.
Open-market sale
SELL$302K
10.5K sh
Sep 14, 2026Sep 15, 2026
traded Sep 14, 2026
+1dSEC Form 4

Evidence

20
PA
Paz AmitCHIEF INNOVATION OFFICER
ENLTEnlight Renewable Energy Ltd.
Open-market sale
SELL$164K
2,221 sh
Sep 14, 2026Sep 15, 2026
traded Sep 14, 2026
+1dSEC Form 4

Evidence

20
SK
Soares KarenChief Legal Officer
CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE
Open-market sale · 10b5-1 plan
SELL$33K
6,846 sh
Sep 15, 2026Sep 15, 2026
traded Sep 15, 2026
+0dSEC Form 4

Evidence

20
Byron DonaldsRSelf
HWMHowmet Aerospace Inc.
Partial sale
SELL$1,001 – $15KAug 11, 2026Sep 15, 2026
traded Aug 11, 2026
+35dHouse PTR

Evidence

20
Byron DonaldsRSpouse
PHParker-Hannifin Corp
Partial sale
SELL$1,001 – $15KAug 11, 2026Sep 15, 2026
traded Aug 11, 2026
+35dHouse PTR

Evidence

20
Byron DonaldsRSelf
PHParker-Hannifin Corp
Partial sale
SELL$1,001 – $15KAug 11, 2026Sep 15, 2026
traded Aug 11, 2026
+35dHouse PTR

Evidence

20
Byron DonaldsRSpouse
HWMHowmet Aerospace Inc.
Partial sale
SELL$1,001 – $15KAug 11, 2026Sep 15, 2026
traded Aug 11, 2026
+35dHouse PTR

Evidence

19
FL
Fuentes LauraSee Remarks
HLTHilton Worldwide Holdings Inc.
Option exercise
M$388K
4,888 sh
Sep 14, 2026Sep 15, 2026
traded Sep 14, 2026
+1dSEC Form 4

Evidence

19
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$492K
2,398 sh
Sep 11, 2026Sep 15, 2026
traded Sep 11, 2026
+4dSEC Form 4

Evidence

19
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$519K
2,190 sh
Sep 14, 2026Sep 15, 2026
traded Sep 14, 2026
+1dSEC Form 4

Evidence

19
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$582K
2,824 sh
Sep 11, 2026Sep 15, 2026
traded Sep 11, 2026
+4dSEC Form 4

Evidence

19
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$440K
1,850 sh
Sep 14, 2026Sep 15, 2026
traded Sep 14, 2026
+1dSEC Form 4

Evidence

19
CJ
Cooke JulieChief Human Resources Officer
NBIXNEUROCRINE BIOSCIENCES INC
Tax withholding
F$302K
1,936 sh
Sep 11, 2026Sep 15, 2026
traded Sep 11, 2026
+4dSEC Form 4

Evidence

19
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$406K
1,720 sh
Sep 14, 2026Sep 15, 2026
traded Sep 14, 2026
+1dSEC Form 4

Evidence

19
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$466K
2,251 sh
Sep 11, 2026Sep 15, 2026
traded Sep 11, 2026
+4dSEC Form 4

Evidence

19
CD
Carr DouglasSVP Finance & Operations
IPSCCentury Therapeutics, Inc.
Open-market sale
SELL$3,200
1,658 sh
Sep 14, 2026Sep 15, 2026
traded Sep 14, 2026
+1dSEC Form 4

Evidence

18
BW
Boyer David W.Chief Corp. Affairs Officer
NBIXNEUROCRINE BIOSCIENCES INC
Open-market sale · 10b5-1 plan
SELL$130K
826 sh
Sep 14, 2026Sep 15, 2026
traded Sep 14, 2026
+1dSEC Form 4

Evidence

18
BC
Brinkley Stephen CPRESIDENT, OPERATIONS
ROSTROSS STORES, INC.
Tax withholding
F$1.54M
6,654 sh
Sep 11, 2026Sep 15, 2026
traded Sep 11, 2026
+4dSEC Form 4

Evidence

17
MN
Mesa NildaDirector
UTHRUNITED THERAPEUTICS Corp
Open-market sale
SELL$50K
98 sh
Sep 14, 2026Sep 15, 2026
traded Sep 14, 2026
+1dSEC Form 4

Evidence

17
HM
Hancock MarkDirector, 10% Owner
PACSPACS Group, Inc.
Open-market sale · 10b5-1 plan
SELL$4.38M
104.1K sh
Sep 15, 2026Sep 15, 2026
traded Sep 15, 2026
+0dSEC Form 4

Evidence

17
MJ
Malm JoshuaChief Financial Officer
FEAM5E Advanced Materials, Inc.
Option exercise
M—
4,261 sh
Sep 15, 2026Sep 15, 2026
traded Sep 15, 2026
+0dSEC Form 4

Evidence

17
FJ
Fengler JustinSee Remarks
GDRXGoodRx Holdings, Inc.
Option exercise
M—
2,335 sh
Sep 15, 2026Sep 15, 2026
traded Sep 15, 2026
+0dSEC Form 4

Evidence

17
CT
Chan Thomas (TC)Chief Accounting Officer
GDRXGoodRx Holdings, Inc.
Option exercise
M—
2,101 sh
Sep 15, 2026Sep 15, 2026
traded Sep 15, 2026
+0dSEC Form 4

Evidence

17
MJ
Malm JoshuaChief Financial Officer
FEAM5E Advanced Materials, Inc.
Option exercise
M—
4,261 sh
Sep 15, 2026Sep 15, 2026
traded Sep 15, 2026
+0dSEC Form 4

Evidence

17
PT
Poleg TamirDirector, Chief Executive Officer
REAXReal REMAX Group Inc.
Option exercise
M—
5,392 sh
Sep 13, 2026Sep 15, 2026
traded Sep 13, 2026
+2dSEC Form 4

Evidence

17
HM
Hancock MarkDirector, 10% Owner
PACSPACS Group, Inc.
Open-market sale · 10b5-1 plan
SELL$1.31M
30.5K sh
Sep 15, 2026Sep 15, 2026
traded Sep 15, 2026
+0dSEC Form 4

Evidence

17
HM
Hancock MarkDirector, 10% Owner
PACSPACS Group, Inc.
Open-market sale · 10b5-1 plan
SELL$6.13M
137.7K sh
Sep 14, 2026Sep 15, 2026
traded Sep 14, 2026
+1dSEC Form 4

Evidence

17
MF
Montoya Michael FChief Technology Ops Officer
FFIVF5, INC.
Open-market sale · 10b5-1 plan
SELL$98K
240 sh
Sep 14, 2026Sep 15, 2026
traded Sep 14, 2026
+1dSEC Form 4

Evidence